awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50047476-5712B96A-BC7F-4569-BC5B-DF22537B9B3C
Q50047476-5712B96A-BC7F-4569-BC5B-DF22537B9B3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50047476-5712B96A-BC7F-4569-BC5B-DF22537B9B3C
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.
P2860
Q50047476-5712B96A-BC7F-4569-BC5B-DF22537B9B3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50047476-5712B96A-BC7F-4569-BC5B-DF22537B9B3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebe1c82fa53baf76a4d519fd29c1f2e1538ba579
P2860
Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance